| Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) Centers for Disease Control and Prevention - ERA · RFA-OH-26-015 | States, Counties, Cities & townships +12 | $18.0M | Dec 8, 2026 |
| IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) National Institutes of Health · RFA-HG-27-008 | States, Counties, Cities & townships +12 | $6.0M | Dec 14, 2026 |
| Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) National Institutes of Health · RFA-HG-27-007 | States, Counties, Cities & townships +12 | $15.0M | Dec 14, 2026 |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) National Institutes of Health · RFA-HG-27-010 | States, Counties, Cities & townships +12 | $5.0M | Dec 14, 2026 |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) National Institutes of Health · RFA-HG-27-009 | States, Counties, Cities & townships +12 | $10.0M | Dec 14, 2026 |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) National Institutes of Health · PAR-25-378 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-379 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-310 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) National Institutes of Health · PAR-25-159 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-235 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-070 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-069 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-256 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) National Institutes of Health · PAR-25-167 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) National Institutes of Health · PAR-25-081 | States, Counties, Cities & townships +12 | $500K | Jan 7, 2027 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-079 | States, Counties, Cities & townships +12 | $500K | Jan 7, 2027 |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-221 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) National Institutes of Health · PAR-25-098 | States, Counties, Cities & townships +12 | — | Jan 7, 2027 |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) National Institutes of Health · PAR-24-214 | Public universities, Private universities, Others | — | Jan 7, 2027 |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) National Institutes of Health · RFA-CA-27-005 | States, Counties, Cities & townships +12 | $4.4M | Jan 11, 2027 |
| Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-071 | States, Counties, Cities & townships +12 | — | Jan 11, 2027 |
| Title X Family Planning Services Grants Office of the Assistant Secretary for Health · PA-FPH-27-001 | States, Counties, Cities & townships +10 | $257.0M | Jan 11, 2027 |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) National Institutes of Health · RFA-NS-25-023 | States, Counties, Cities & townships +12 | — | Jan 15, 2027 |
| Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) National Institutes of Health · PAR-28-062 | School districts, Public universities, Nonprofits (501c3) +2 | — | Jan 25, 2027 |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34) National Institutes of Health · PAR-24-236 | Public universities, Tribal governments, Tribal organizations +2 | — | Jan 25, 2027 |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) National Institutes of Health · PAR-24-235 | Public universities, Tribal governments, Tribal organizations +2 | — | Jan 25, 2027 |
| Medical Scientist Training Program (MSTP) (T32) National Institutes of Health · PAR-24-128 | States, Counties, Cities & townships +12 | — | Jan 25, 2027 |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-28-012 | States, Counties, Cities & townships +12 | — | Jan 26, 2027 |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) National Institutes of Health · RFA-DA-28-011 | States, Counties, Cities & townships +12 | — | Jan 26, 2027 |
| National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed) National Institutes of Health · PAR-26-138 | States, Counties, Cities & townships +12 | — | Jan 26, 2027 |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) National Institutes of Health · RFA-AA-28-001 | States, Counties, Cities & townships +12 | $1.5M | Jan 27, 2027 |
| Diabetes Research Centers (P30 Clinical Trial Optional) National Institutes of Health · RFA-DK-26-310 | States, Counties, Cities & townships +12 | $18.2M | Jan 27, 2027 |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) National Institutes of Health · PAR-24-268 | Public universities, Nonprofits (501c3), Nonprofits (other) +2 | — | Jan 27, 2027 |
| Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) National Institutes of Health · PAR-24-260 | Tribal governments, Others | — | Jan 27, 2027 |
| Translational Neural Devices (R61/R33 - Clinical Trial Optional) National Institutes of Health · PAR-25-053 | States, Counties, Cities & townships +12 | — | Jan 28, 2027 |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) National Institutes of Health · RFA-NS-24-031 | States, Counties, Cities & townships +12 | — | Jan 28, 2027 |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) National Institutes of Health · RFA-AI-28-012 | States, Counties, Cities & townships +12 | $7.0M | Jan 29, 2027 |
| Immune Tolerance Network (UM1 Clinical Trial Required) National Institutes of Health · RFA-AI-28-005 | States, Counties, Cities & townships +12 | $22.0M | Jan 29, 2027 |
| Minor Use Minor Species Development of Drugs (R01) Food and Drug Administration · PAR-24-216 | States, Counties, Cities & townships +12 | $250K | Jan 29, 2027 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-25-026 | States, Counties, Cities & townships +12 | — | Feb 3, 2027 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) National Institutes of Health · PAR-25-025 | States, Counties, Cities & townships +12 | — | Feb 3, 2027 |
| Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-28-013 | States, Counties, Cities & townships +12 | $4.0M | Feb 8, 2027 |
| BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-MH-26-170 | States, Counties, Cities & townships +12 | — | Feb 8, 2027 |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-CA-28-013 | States, Counties, Cities & townships +12 | $800K | Feb 9, 2027 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) National Institutes of Health · RFA-DK-27-119 | States, Counties, Cities & townships +12 | $4.8M | Feb 10, 2027 |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) National Institutes of Health · RFA-LM-28-001 | States, Counties, Cities & townships +12 | $17.1M | Feb 11, 2027 |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) National Institutes of Health · RFA-CA-28-004 | Others | $19.0M | Feb 11, 2027 |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) National Institutes of Health · RFA-AI-28-024 | States, Counties, Cities & townships +12 | $4.0M | Feb 11, 2027 |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) National Institutes of Health · RFA-DC-27-004 | States, Counties, Cities & townships +12 | $6.0M | Feb 11, 2027 |
| NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-24-269 | States, Counties, Cities & townships +12 | — | Feb 11, 2027 |